Back to the news

Companies

Hester Biosciences Q2 Results: Shares jump 8% after profit rises 41%, revenue grows 38%

Reported by: CNBC TV18 ·

WhatsApp

Hester Biosciences

Summary

CNBC TV18 reported that Hester Biosciences' net profit for Q2 rose 41% and revenue grew 38%, and its shares rose 8% after the results. Q2 is the July to September quarter, the second quarter of India's financial year. Net profit is what is left after all costs and tax. The same report said the board approved an unsecured loan of $1 million to its wholly owned subsidiary, Hester Biosciences Africa Ltd., based in Tanzania. An unsecured loan is one given without any asset pledged as security. The loan will be given in one or more tranches, meaning in parts. A wholly owned subsidiary is a company the parent owns fully. The report did not give the profit or revenue figures in rupees.

AI summary of what CNBC TV18 reported. AI can make mistakes. Read the full story on CNBC TV18

Learn: What is an exchange filing?

Sources

Every outlet that reported this story. Each link opens the outlet's own article.

What each outlet wrote

The same news, in each outlet's own headline. Open one to read their full story.

CNBC TV18  · · Tone +3

Hester Biosciences Q2 Results: Shares jump 8% after profit rises 41%, revenue grows 38%

The board of Hester Biosciences has approved an unsecured loan of $1 million to its wholly owned subsidiary, Hester Biosciences Africa Ltd., based in Tanzania. The loan will be disbursed in one or more tranches and will…

Some headlines quote an analyst. Those views are theirs, not ours.

Key terms

Words in this story, explained in plain language in our Learn pages.

  • Q2

    Revenue, profit, margins and EPS: what the numbers in a quarterly result mean, why year-on-year and quarter-on-quarter differ, and what a headline can leave out.

    Learn: How to read a company's results

Ask Hypeless about this story

Ask what it means, what a term in it means, or what other outlets said. Answers use only these outlets' headlines.

Ask Hypeless